279 related articles for article (PubMed ID: 28132012)
1. Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study.
Wolf HT; Huusom L; Weber T; Piedvache A; Schmidt S; Norman M; Zeitlin J;
BMJ Open; 2017 Jan; 7(1):e013952. PubMed ID: 28132012
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey.
Long Q; Oladapo OT; Leathersich S; Vogel JP; Carroli G; Lumbiganon P; Qureshi Z; Gülmezoglu AM;
BJOG; 2017 Nov; 124(12):1883-1890. PubMed ID: 27885772
[TBL] [Abstract][Full Text] [Related]
3. Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey.
Chollat C; Le Doussal L; de la Villéon G; Provost D; Marret S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):304. PubMed ID: 28903747
[TBL] [Abstract][Full Text] [Related]
4. Magnesium sulfate exposure and neonatal intensive care unit admission at term.
Girsen AI; Greenberg MB; El-Sayed YY; Lee H; Carvalho B; Lyell DJ
J Perinatol; 2015 Mar; 35(3):181-5. PubMed ID: 25321647
[TBL] [Abstract][Full Text] [Related]
5. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
[TBL] [Abstract][Full Text] [Related]
6. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
7. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
8. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
[TBL] [Abstract][Full Text] [Related]
9. Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.
Lu JF; Nightingale CH
Clin Pharmacokinet; 2000 Apr; 38(4):305-14. PubMed ID: 10803454
[TBL] [Abstract][Full Text] [Related]
10. Neonatal magnesium levels are safe after maternal MgSO
Dehaene I; Van Steenstraeten T; De Coen K; De Buyser S; Decruyenaere J; Smets K; Roelens K
Eur J Pediatr; 2022 Aug; 181(8):2971-2980. PubMed ID: 35595861
[TBL] [Abstract][Full Text] [Related]
11. [Magnesium sulfate in obstetrics: current data].
Azria E; Tsatsaris V; Goffinet F; Kayem G; Mignon A; Cabrol D
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 1):510-7. PubMed ID: 15567967
[TBL] [Abstract][Full Text] [Related]
12. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
[TBL] [Abstract][Full Text] [Related]
13. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
Singh J; O'Donovan M; Coulter-Smith SD; Geary M
J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
[TBL] [Abstract][Full Text] [Related]
14. The WHO Safe Childbirth Checklist implementation: impact on the prescription of magnesium sulphate through a one-year longitudinal study.
da Silva Gama ZA; Medeiros WR; Saturno-Hernández PJ; de Meneses Sousa K; Mello MS; de Lima Vale É; de Souza Rosendo TMS; da Silva EMM; de Freitas MR
BMC Pregnancy Childbirth; 2020 Mar; 20(1):154. PubMed ID: 32164643
[TBL] [Abstract][Full Text] [Related]
15. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
16. Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.
Ridge AL; Bero LA; Hill SR
BMC Health Serv Res; 2010 Dec; 10():340. PubMed ID: 21162717
[TBL] [Abstract][Full Text] [Related]
17. [Hypocalcemic delirium due to magnesium sulphate therapy in a pregnant woman with pre-eclampsia].
Ganzevoort JW; Hoogerwaard EM; van der Post JA
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1453-6. PubMed ID: 12190013
[TBL] [Abstract][Full Text] [Related]
18. Maternal and perinatal outcomes of eclampsia: Nova Scotia, 1981-2000.
Lee W; O'Connell CM; Baskett TF
J Obstet Gynaecol Can; 2004 Feb; 26(2):119-23. PubMed ID: 14965477
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
Eddy KE; Vogel JP; Zahroh RI; Bohren MA
BJOG; 2022 Feb; 129(3):379-391. PubMed ID: 34520111
[TBL] [Abstract][Full Text] [Related]
20. Correlation of magnesium levels in cord blood and maternal serum among pre-eclamptic pregnant women treated with magnesium sulfate.
Boriboonhirunsarn D; Lertbunnaphong T; Suwanwanich M
J Obstet Gynaecol Res; 2012 Jan; 38(1):247-52. PubMed ID: 22136102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
